Position 1: Research Scientist (closed)

Position overview

We are seeking a Research Scientist with expertise in biochemistry and immunology and a strong background in laboratory work such as in vitro experiments and production of recombinant proteins. As a key member of our preclinical development team, you’ll focus on tolerogenic vaccine development for curative and preventive treatment of autoimmunity, specifically targeting different subtypes of rheumatoid arthritis.


You are expected to work independently from research planning to data acquisition, data processing and analysis, to interpretation and reporting in a timely manner as an expert in the project team.

Specific requirements

- Doctoral or Master of Science degree in Biochemistry, Biotechnology, Immunology, or a related field.

- Immunological expertise and methodological excellence

- Prior experience in pre-clinical drug development and in vivo experimentation is an asset.

- Proficient knowledge of both written and spoken English

- Collaborative and communications skills for smooth co-operation in the team

We place great importance on personal suitability and are looking for highly creative and motivated employees, have a proactive way to work and appreciate working in a team. We expect the applicants to show good cooperation skills and at the same time great independence.

What do we offer?

- Inspiring and international environment with a creative and collaborative team.

- Work with team with leading experts, access cutting-edge resources and technologies.

- Impactful work: contribute to transformative discoveries in autoimmune disease treatment.

- Dynamic atmosphere of a small company.

The position provides a trial period of no longer than 6 months followed by a fixed employment, starting on 1st June 2024, in total 2 years, with the possibility of further extension.


Your application should include, in English or Swedish:

- A complete resumé, including the date of the thesis defence, title of the thesis, previous positions, academic title, current position, and job descriptions in brief.

- A complete list of publications

- Motivation letter (max 1 A4)

Welcome to apply at the latest 22nd April 2024.

The application is to be submitted by email to info@vacara.se.

Join us in shaping the future of autoimmune therapies. Apply today!

About us

At Vacara AB we have a mission to revolutionize autoimmune disease treatment. Our team of passionate scientists and innovators is dedicated to developing groundbreaking solutions to combat autoimmunity. Join us in our pursuit of scientific excellence!

Vacara develops a tolerizing vaccine (AID001), together with the Fraunhofer Institute and aidCURE AG in Germany. AID001 is developed for treatment and prevention of rheumatoid arthritis. The cutting-edge vaccine downregulates the autoimmune attack on the joints which is achieved by inducing the activity of regulatory T cells. Vacara has developed exceptional humanized mouse models with physiologic expression of chimeric MHC class II alleles, ideal for testing the AID001 vaccine in vivo.


This project has received funding from the Eurostars 3-program as well as from the European Union's research and innovation program Horizon Europe.

Eurostars is part of the European Partnership on Innovative SMEs. The partnership is co-funded by the European Union through Horizon Europe.


Please send your application to